NCT05549570View on ClinicalTrials.gov

Comparative Bioavailability Study of Metformin/Sitagliptin 850 mg/50 mg Tablets in Healthy Male and Female Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

October 22, 2017

Primary Completion Date

November 1, 2017

Study Completion Date

November 1, 2017

Conditions
BioequivalenceDiabetes Mellitus, Type 2
Interventions
DRUG

Sitagliptin/Metformin HCl 50/850 mg film-coated tablet

The subjects randomly received single oral dose of Sitagliptin/Metformin HCl 50/850 mg film-coated tablet

Trial Locations (1)

H3P 3P1

Algorithme Pharma, Mount Royal

Sponsors

Lead Sponsor

Galenicum Health
All Listed Sponsors
lead

Galenicum Health

INDUSTRY

NCT05549570 - Comparative Bioavailability Study of Metformin/Sitagliptin 850 mg/50 mg Tablets in Healthy Male and Female Volunteers | Biotech Hunter | Biotech Hunter